Oncolytics Biotech (ONCY) Asset Utilization Ratio (2009 - 2020)
Oncolytics Biotech (ONCY) posted quarterly Asset Utilization Ratio of 3.54 for Q3 2020, down 100.0% year-over-year from 1983449.46 in Q4 2019, and up 21.65% quarter-over-quarter from 2.91 in Q2 2020.
Oncolytics Biotech (ONCY) Asset Utilization Ratio (2009 - 2020) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Asset Utilization Ratio for 7 consecutive years, with 3.54 the latest figure, recorded in Q3 2020.
- In Q3 2020, Asset Utilization Ratio fell 100.0% year-over-year to 3.54; the TTM figure through Sep 2020 stood at 3.54 (down 100.0% YoY), while the FY2018 annual figure was 1167299.49, changed N/A from the prior year.
- Asset Utilization Ratio grew to 3.54 in Q3 2020 per ONCY's latest filing, from 2.91 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 2301017.6 in Q1 2019 and bottomed at 0.0 in Q2 2016.
- Historically, Asset Utilization Ratio has averaged 800170.9 across 5 years, with a median of 347601.36 in 2018.
- Annual changes were most pronounced in 2017 — Asset Utilization Ratio jumped 9909294.12% — and 2020, when it sank 100.0%.
- Oncolytics Biotech's Asset Utilization Ratio stood at 0.0 in 2016, then surged by 9909294.12% to 0.0 in 2017, then surged by 978015811980838.9% to 1049571.0 in 2018, then jumped by 88.98% to 1983449.46 in 2019, then plunged by 100.0% to 3.54 in 2020.
- Business Quant data shows ONCY's Asset Utilization Ratio at 3.54 in Q3 2020, 2.91 in Q2 2020, and 665852.62 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.54 |
| Jun 30, 2020 | 2.91 |
| Mar 31, 2020 | 665,852.62 |
| Sep 30, 2019 | 1.98 Mn |
| Jun 30, 2019 | 1.97 Mn |
| Mar 31, 2019 | 2.30 Mn |
| Dec 31, 2018 | 1.05 Mn |
| Sep 30, 2018 | 29,350.10 |
| Jun 30, 2017 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Jun 30, 2010 | 0.83 |
| Sep 30, 2009 | 4.07 |
| Jun 30, 2009 | 4.44 |
| Mar 31, 2009 | 5.26 |